Total Payments
$1,361
2024 Payments
$290.11
Companies
12
Transactions
34
Medicare Patients
7,393
Medicare Billing
$3.6M
Payment Breakdown by Category
Food & Beverage$1,361 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,361 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $442.34 | 4 | $0 (2018) |
| ABBVIE INC. | $211.46 | 12 | $0 (2024) |
| Genentech USA, Inc. | $131.29 | 6 | $0 (2024) |
| Allergan Inc. | $124.99 | 2 | $0 (2017) |
| Apellis Pharmaceuticals, Inc. | $122.61 | 1 | $0 (2023) |
| Alcon Vision LLC | $120.34 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $49.11 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $45.93 | 1 | $0 (2018) |
| Alimera Sciences, Inc. | $44.80 | 2 | $0 (2019) |
| Harrow Eye, LLC | $30.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $290.11 | 8 | Alcon Vision LLC ($120.34) |
| 2023 | $235.82 | 7 | Apellis Pharmaceuticals, Inc. ($122.61) |
| 2022 | $133.92 | 8 | ABBVIE INC. ($65.47) |
| 2021 | $20.77 | 1 | Genentech USA, Inc. ($20.77) |
| 2019 | $44.80 | 2 | Alimera Sciences, Inc. ($44.80) |
| 2018 | $195.88 | 2 | Alcon Laboratories Inc ($149.95) |
| 2017 | $439.41 | 6 | Alcon Laboratories Inc ($292.39) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: OPTOMETRY | ||||||
| 09/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: EYE CARE | ||||||
| 04/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: EYE CARE | ||||||
| 03/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: EYE CARE | ||||||
| 02/29/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $120.34 | General |
| Category: Ophthalmology | ||||||
| 01/26/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: EYE CARE | ||||||
| 12/01/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: EYE CARE | ||||||
| 09/28/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: EYE CARE | ||||||
| 09/20/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $21.49 | General |
| 06/21/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: EYE CARE | ||||||
| 05/04/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $122.61 | General |
| Category: Ophthalmology | ||||||
| 03/13/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: EYE CARE | ||||||
| 01/17/2023 | Genentech USA, Inc. | Lucentis (Biological), Vabysmo | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Ophthalmology | ||||||
| 11/02/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RETINA | ||||||
| 08/19/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: RETINA | ||||||
| 08/17/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/10/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $30.77 | General |
| 05/25/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: RETINA | ||||||
| 03/22/2022 | Genentech USA, Inc. | Lucentis (Biological), SUSVIMO, VABYSMO | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Ophthalmology | ||||||
| 03/22/2022 | Genentech USA, Inc. | Lucentis (Biological), SUSVIMO, VABYSMO | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Ophthalmology | ||||||
| 03/11/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RETINA | ||||||
| 07/14/2021 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Ophthalmology | ||||||
| 07/24/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,694 | 15,953 | $4.4M | $1.6M |
| 2022 | 13 | 2,237 | 7,035 | $3.0M | $1.1M |
| 2021 | 13 | 1,769 | 5,295 | $2.0M | $757,552 |
| 2020 | 7 | 693 | 1,703 | $323,614 | $125,235 |
Total Patients
7,393
Total Services
29,986
Medicare Billing
$3.6M
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 123 | 1,286 | $2.5M | $882,604 | 35.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 33 | 7,620 | $558,600 | $220,063 | 39.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 654 | 1,712 | $444,846 | $152,067 | 34.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 238 | 1,266 | $262,670 | $117,379 | 44.7% |
| 92134 | Imaging of retina | Office | 2023 | 791 | 2,456 | $206,500 | $71,628 | 34.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 157 | 695 | $110,575 | $37,631 | 34.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 14 | 203 | $81,034 | $29,795 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 153 | 153 | $51,218 | $16,503 | 32.2% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 18 | 19 | $44,852 | $16,352 | 36.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 136 | 136 | $42,141 | $13,202 | 31.3% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 13 | 13 | $31,956 | $11,862 | 37.1% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 18 | 33 | $31,350 | $8,046 | 25.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 265 | 273 | $13,650 | $4,645 | 34.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 18 | 21 | $22,831 | $3,570 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $9,727 | $3,188 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $4,221 | $1,615 | 38.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 12 | 12 | $2,189 | $820.80 | 37.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 13 | $1,418 | $474.95 | 33.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 85 | 974 | $1.9M | $694,662 | 37.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 535 | 1,353 | $351,564 | $120,718 | 34.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 212 | 1,142 | $236,942 | $105,083 | 44.3% |
| 92134 | Imaging of retina | Office | 2022 | 678 | 2,193 | $184,387 | $65,597 | 35.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 155 | 788 | $125,371 | $41,878 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 196 | 196 | $65,613 | $22,935 | 35.0% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 21 | 23 | $54,294 | $20,683 | 38.1% |
About Dr. Kruti Dajee, M.D
Dr. Kruti Dajee, M.D is a Ophthalmology healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1043506215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kruti Dajee, M.D has received a total of $1,361 in payments from pharmaceutical and medical device companies, with $290.11 received in 2024. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,361).
As a Medicare-enrolled provider, Dajee has provided services to 7,393 Medicare beneficiaries, totaling 29,986 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Mckinney, TX
- Active Since 06/25/2011
- Last Updated 07/05/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1043506215
Products in Payments
- OZURDEX (Drug) $336.45
- AcrySof (Device) $193.88
- ACTIVEFOCUS (Device) $149.95
- Syfovre (Drug) $122.61
- Clareon (Device) $120.34
- Centurion (Device) $98.51
- Lucentis (Biological) $68.03
- BROLUCIZUMAB (Drug) $45.93
- Iluvien (Drug) $44.80
- Vabysmo (Drug) $32.49
- IHEEZO (Drug) $30.33
- Izervay (Drug) $27.62
- ACTHAR (Biological) $22.03
- EYLEA (Biological) $15.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Mckinney
Dr. Jason Bullajian, Md, MD
Ophthalmology — Payments: $60,733
Ophthalmology $60,733
Sanjay Patel, Md, MD
Ophthalmology — Payments: $8,954
Ophthalmology $8,954
Dr. Hena Khaja, Md, MD
Ophthalmology — Payments: $3,999
Ophthalmology $3,999
Rudolf Churner, Md, MD
Ophthalmology — Payments: $2,545
Ophthalmology $2,545
Archana Nair, Md, MD
Ophthalmology — Payments: $2,157
Ophthalmology $2,157
Joshua Heczko, Md, MD
Ophthalmology — Payments: $1,790
Ophthalmology $1,790